NEURO-ONCOLOGY Late neurocognitive decline after radiotherapy for low-grade glioma

被引：29

作者：

Khasraw, Mustafa ^{[1
,2
]}

Lassman, Andrew B. ^{[1
,2
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA

[2] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10065 USA

来源：

NATURE REVIEWS NEUROLOGY | 2009年 / 5卷 / 12期

关键词：

OLIGODENDROGLIOMA; SURVIVAL; ADULTS; BRAIN;

D O I：

10.1038/nrneurol.2009.194

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Radiotherapy is administered to most patients with low-grade glioma. a well-designed, retrospective study assessed neurocognitive function in patients who had received radiotherapy for low-grade gliomas versus those who had not. Cognitive function did not differ markedly between groups after 6 years, but by 12 years this feature was worse in the group that received radiotherapy.

引用

页码：646 / 647

页数：3

共 11 条

[1] RADIATION-INDUCED DEMENTIA IN PATIENTS CURED OF BRAIN METASTASES [J].

DEANGELIS, LM ;

DELATTRE, JY ;

POSNER, JB .

NEUROLOGY, 1989, 39 (06) :789-796

[2] Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up [J].

Douw, Linda ;

Klein, Martin ;

Fagel, Selene S. A. A. ;

van den Heuvel, Josje ;

Taphoorn, Martin J. B. ;

Aaronson, Neil K. ;

Postma, Tjeerd J. ;

Vandertop, W. Peter ;

Mooij, Jacob J. ;

Boerman, Rudolf H. ;

Beute, Guus N. ;

Sluimer, Jasper D. ;

Slotman, Ben J. ;

Reijneveld, Jaap C. ;

Heimans, Jan J. .

LANCET NEUROLOGY, 2009, 8 (09) :810-818

[3] Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study [J].

Klein, M ;

Heimans, JJ ;

Aaronson, NK ;

van der Ploeg, HM ;

Grit, J ;

Muller, M ;

Postma, TJ ;

Mooij, JJ ;

Boerman, RH ;

Beute, GN ;

Ossenkoppele, GJ ;

van Imhoff, GW ;

Dekker, AW ;

Jolles, J ;

Slotman, BJ ;

Struikmans, H ;

Taphoorn, MJB .

LANCET, 2002, 360 (9343) :1361-1368

[4]

Lassman AB, 2009, NEURO-ONCOLOGY, V11, P629

[5]

Louis DN., 2007, WHO CLASSIFICATION T

[6] Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy [J].

Mariani, Luigi ;

Deiana, Gianluca ;

Vassella, Erik ;

Fathi, Ali-Reza ;

Murtin, Christine ;

Arnold, Marlene ;

Vajtai, Istvan ;

Weis, Joachim ;

Siegenthaler, Peter ;

Schobesberger, Martina ;

Reinert, Michael M. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) :4758-4763

[7] Long-term outcome of low-grade oligodendroglioma and mixed glioma [J].

Olson, JD ;

Riedel, E ;

DeAngelis, LM .

NEUROLOGY, 2000, 54 (07) :1442-1448

[8] Postoperative radiotherapy in the treatment of single metastases to the brain - A randomized trial [J].

Patchell, RA ;

Tibbs, PA ;

Regine, WF ;

Dempsey, RJ ;

Mohiuddin, M ;

Kryscio, RJ ;

Markesbery, WR ;

Foon, KA ;

Young, B .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17) :1485-1489

[9] Prognostic factors for survival in adult patients with cerebral low-grade glioma [J].

Pignatti, F ;

van den Bent, M ;

Curran, D ;

Debruyne, C ;

Sylvester, R ;

Therasse, P ;

Afra, D ;

Cornu, P ;

Bolla, M ;

Vecht, C ;

Karim, ABMF .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) :2076-2084

[10]

Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337

← 1 2 →